Ann: ASCO Presentation of SIRFLOX Results, page-5

The detail all looks very encouraging to me. I am interested that the language of the summary is less positive than I expected, i.e. "sales in first-line mCRC are achievable", "increased utilisation will gain momentum over time" and "incorporation into clinical practice beyond the current salvage setting is now a realistic possibility." "Achievable" and "realistic possibility" both suggest more doubt than I would have expected while "over time" implies that change is quite some way off. I certainly don't think they can be accused of exaggerating the upside.